ENDPOINTS

Regeneron gets $400M+ jury win in Amgen cholesterol drug case

A Delaware jury on Thursday said Regeneron should get more than $400 million in damages in its long-running antitrust case against Amgen. Regeneron brought the case almost three years ago alleging ...

May 15, 2025 - 22:24
 0
Regeneron gets $400M+ jury win in Amgen cholesterol drug case
A Delaware jury on Thursday said Regeneron should get more than $400 million in damages in its long-running antitrust case against Amgen. Regeneron brought the case almost three years ago alleging ...
Read More

Tags:

Previous Article

This week in science: biker safety, orange cats and a gum disease-heart rhythm link

Next Article

The world’s richest people have an outsized role in climate extremes

Related Posts

How Toyota Owners Can Extend Vehicle Life with OEM Parts

May 12, 2025  0

Galapagos backpedals on separation plans, CEO Paul Stoffels exits early

Galapagos backpedals on separation plans, CEO Paul Stof...

May 13, 2025  0

AGC Bio secures lentiviral contract; Thermo Fisher to make Cybin asset

AGC Bio secures lentiviral contract; Thermo Fisher to m...

May 15, 2025  0